Latest Lead News

McLaren Minerals has successfully raised $1.282 million through a two-tranche placement to advance its McLaren Titanium Project in Western Australia, aiming to complete a critical pre-feasibility study by early Q3 2025.

Opyl Limited has secured strategic collaborations with two leading contract research organisations, integrating its AI-driven TrialKey platform into cardiovascular, oncology, and rare disease clinical trials to enhance trial design and accelerate commercial growth.

Hastings Technology Metals appoints Vince Catania as CEO, entrusting him with advancing the Yangibana Rare Earths Project and broader portfolio development.

Telix Pharmaceuticals showcased its global theranostic radiopharmaceutical portfolio, highlighting FDA approvals, clinical progress, and a robust commercial expansion plan at its 2025 Investor Day.

EVE Health Group has launched a $1.5 million capital raise alongside the acquisition of biotech firm Nextract, aiming to expand its footprint in health and pharmaceutical products focused on erectile dysfunction and period pain.

Tower Limited has confirmed Paul Johnston as its permanent CEO after a successful interim period, while initiating a search for a new CFO to sustain its financial leadership.

Asara Resources has received a significant cash payment from Teck Resources Chile following the resolution of a legal dispute, marking a key milestone in their joint venture for the Loreto Copper Project.

St George Mining has initiated a 10,000-metre drilling program at its Araxá Project in Brazil, aiming to significantly grow its already substantial rare earths and niobium resource. The campaign combines multiple drilling techniques alongside a high-resolution airborne magnetic survey to unlock further mineral potential.

FOS Capital is set to acquire Aldridge Traffic Systems' street lighting assets for $3.1 million, backed by a $3.7 million equity raise to fund the deal and expansion plans.

Resolution Minerals Ltd has entered a binding agreement to acquire the Horse Heaven Project in Idaho, a promising antimony-gold-silver-tungsten asset adjacent to a major US mine, with drilling planned for 2025.

North Stawell Minerals has launched a $3.6 million equity raising, anchored by a cornerstone investor, to fund exploration at key Victorian gold projects and sustain operational momentum through 2025.

PYC Therapeutics has secured Safety Review Committee approval to increase dosing in its clinical trial for a novel treatment targeting Autosomal Dominant Optic Atrophy, a rare blinding genetic disease. This milestone marks a significant step forward in the development of PYC-001, a first-in-class RNA therapy.